GHK-CU
Find your strength. Choose your bundle.
COA status by strength50 mg COA published; 100 mg documentation pending
Earn up to $3.50 back on this itemLazarus Pass · 1–5% store credit + free shipping protection · A$19.95/moA closer
look.
GHK-Cu (copper peptide) — also written GHK Cu or GHKCu — is a naturally occurring tripeptide that binds a single copper ion.
It is among the more extensively studied copper-binding peptides in the research literature, where interest centres on how it interacts with copper and on processes related to collagen synthesis, enzyme activity, and cellular repair.
Research details & references
Last reviewed:
Lazarus Labs supplies GHK-Cu in Australia in 50MG and 100MG blue lyophilised vial options for controlled laboratory research.
What is GHK-Cu?
Why researchers choose Lazarus Labs
The current 50MG batch has published third-party HPLC and LC-MS documentation. The new 100MG batch does not yet have a published Certificate of Analysis; its documentation status is shown as pending until a report is available.
Product highlights
- Available strengths: 50MG and 100MG
- Documentation: 50MG COA published; 100MG COA pending
- Appearance: characteristic blue lyophilised powder
- Solubility: readily soluble in water (H2O)
- Manufacturing: GMP + ISO 9001:2008 compliant
- Intended use: copper-peptide and cellular-response research
Handling & storage
Store sealed and dry at 2–8 °C, and follow your laboratory’s own handling and stability procedures once reconstituted. For research use only — not for human or veterinary use.
Read the citation-backed research overview →
Cited research
- Pickart L, Margolina A International Journal of Molecular Sciences. 2018. PMID: 29986520.
- Pickart L, Vasquez-Soltero JM, Margolina A Oxidative Medicine and Cellular Longevity. 2012. PMID: 22666519.
- Siméon A, Emonard H, Hornebeck W, Maquart FX Life Sciences. 2000. PMID: 11045606.
- Dou Y, Lee A, Zhu L, Morton J, Ladiges W Aging Pathobiology and Therapeutics. 2020. PMID: 35083444.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Size
- 50MG, 100MG
- Product
- GHK-CU
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Lazarus batch report
- Batch
- LL-GHKCU-0125
- Report
- #110531
- Tested
- 2026-08-07
- Reported purity
- 99.540%
50 mg COA published; 100 mg documentation pending. A report for one strength does not verify another.
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →Frequently bought together.
You may also like
-
Metabolic researchCOA verified
Retatrutide
Lazarus Labs Retatrutide delivers premium batch quality with third-party COA support and available 10MG / 20MG strength options.Dispatched from Western Australia within 24 hours. Free express shipping over $300 with AusPost tracking.
-
Recovery researchCOA verified
-
Metabolic researchCOA verified
-
Metabolic researchCOA verified
